Division of Experimental Medicine, Department of Medicine, University of California San Francisco, and HIV/AIDS Division, San Francisco General Hospital, San Francisco, CA 94110, USA.
Eur J Immunol. 2010 Jan;40(1):134-41. doi: 10.1002/eji.200939258.
The complexity of immunoregulation has focused attention on the CD4+ T "suppressor" regulatory cell (Treg), which helps maintain balance between immunity and tolerance. An immunoregulatory T-cell population that upon activation amplifies cellular immune responses was described in murine models more than 30 years ago; however, no study has yet identified a naturally occurring T "inducer" cell type. Here, we report that the ectoenzyme CD39/NTPDase1 (ecto-nucleoside triphosphate diphosphohydrolase 1) helps to delineate a novel population of human "inducer" CD4+ T cells (Tind) that significantly increases the proliferation and cytokine production of responder T cells in a dose-dependent manner. Furthermore, this unique Tind subset produces a distinct repertoire of cytokines in comparison to the other CD4+ T-cell subsets. We propose that this novel CD4+ T-cell population counterbalances the suppressive activity of suppressor Treg in peripheral blood and serves as a calibrator of immunoregulation.
免疫调节的复杂性使人们关注 CD4+T“抑制”调节细胞(Treg),它有助于维持免疫和耐受之间的平衡。30 多年前在鼠模型中描述了一种具有免疫调节作用的 T 细胞群体,其在激活后可扩增细胞免疫反应;然而,目前尚无研究鉴定出天然存在的 T“诱导”细胞类型。在这里,我们报告细胞外酶 CD39/NTPDase1(ecto-核苷三磷酸二磷酸水解酶 1)有助于描绘一种新型的人类“诱导”CD4+T 细胞(Tind)群体,该群体以剂量依赖的方式显著增加效应 T 细胞的增殖和细胞因子产生。此外,与其他 CD4+T 细胞亚群相比,这个独特的 Tind 亚群产生了不同的细胞因子谱。我们提出,这种新型 CD4+T 细胞群体可以平衡外周血中抑制性 Treg 的抑制活性,并作为免疫调节的校准器。